These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14596632)

  • 1. The potential and limitations of personalized medicine in the doctor-patient relationship.
    Hapgood R
    Pharmacogenomics; 2003 Nov; 4(6):685-7. PubMed ID: 14596632
    [No Abstract]   [Full Text] [Related]  

  • 2. How personalized medicine is changing the rules of drug life exclusivity.
    Sullivan CG
    Pharmacogenomics; 2004 Jun; 5(4):429-32. PubMed ID: 15165178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics and public policy: expert views in Europe and North America.
    Melzer D; Detmer D; Zimmern R
    Pharmacogenomics; 2003 Nov; 4(6):689-91. PubMed ID: 14596633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical considerations on pharmacogenomics.
    Mordini E
    Pharmacol Res; 2004 Apr; 49(4):375-9. PubMed ID: 15202517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of data privacy could hamper pharmacogenomics studies.
    Howard K
    Nat Rev Drug Discov; 2004 Sep; 3(9):725. PubMed ID: 15368651
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics: ethical issues.
    Sutrop M
    Bioethics; 2004 Aug; 18(4):iii-viii. PubMed ID: 15449403
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuffield Council on Bioethics consultation.
    Lipton P
    Pharmacogenomics; 2003 Jan; 4(1):91-5. PubMed ID: 12517289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized pharmacogenetic therapy: a critical analysis.
    Schmedders M; van Aken J; Feuerstein G; Kollek R
    Community Genet; 2003; 6(2):114-9. PubMed ID: 14560072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives from the clinic: will the average physician embrace personalized medicine?
    Levy H; Young JH
    Clin Pharmacol Ther; 2008 Mar; 83(3):492-3. PubMed ID: 18253143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation treatment: pharmacogenetic assessment.
    Munafò MR; Lerman C; Niaura R; Shields AE; Swan GE
    Curr Opin Mol Ther; 2005 Jun; 7(3):202-8. PubMed ID: 15977416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored medicine: whom will it fit? The ethics of patient and disease stratification.
    Smart A; Martin P; Parker M
    Bioethics; 2004 Aug; 18(4):322-42. PubMed ID: 15449405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical implications of pharmacogenetics--do slippery slope arguments matter?
    Schubert L
    Bioethics; 2004 Aug; 18(4):361-78. PubMed ID: 15449407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhetoric and hype: where's the 'ethics' in pharmacogenomics?
    Williams-Jones B; Corrigan OP
    Am J Pharmacogenomics; 2003; 3(6):375-83. PubMed ID: 14672518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns].
    Daudén E
    Actas Dermosifiliogr; 2007; 98(1):3-13. PubMed ID: 17374327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and personalized medicine: mapping of future value creation.
    Hu SX; Foster T; Kieffaber A
    Biotechniques; 2005 Oct; 39(10 Suppl):S1-6. PubMed ID: 18957035
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics and ethical considerations: why care?
    Marx-Stölting L
    Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fragmentation of the doctor-patient relationship as a result of standardisation and economisation].
    Kienzle HF
    Z Arztl Fortbild Qualitatssich; 2004 May; 98(3):193-9; discussion 206, 213-5. PubMed ID: 15250386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.